Biopharm boosts sales for Nabi
Nabi Biopharmaceuticals saw biopharmaceutical product sales - driven by strong growth in sales of Nabi-HB - reaching record levels of $89.5 million (€83m) in 2002, a 22 per cent increase from 2001 levels.
News & Analysis on the Clinical Development and Manufacture of Large Molecule Drugs